2-Methyl-4-methoxymethyl-5-cyano-6-oxypyridine → 3-(aminomethyl)-4-(methoxymethyl)-6-methyl-2(1H)-Pyridinone

HRID 62380ノート

反応式

HRID 62380 の反応式
[CH3:1][C:2]1[NH:7][C:6](=[O:8])[C:5]([C:9]#[N:10])=[C:4]([CH2:11][O:12][CH3:13])[CH:3]=1>C(O)(=O)C.[Ni]>[NH2:10][CH2:9][C:5]1[C:6](=[O:8])[NH:7][C:2]([CH3:1])=[CH:3][C:4]=1[CH2:11][O:12][CH3:13]

参加物

4

実験手順

6-Methyl-4-[(methyloxy)methyl]-2-oxo-1,2-dihydro-3-pyridinecarbonitrile (1.000 g, 5.61 mmol) was suspended in acetic acid (150 ml) and the solution passed through an H-cube instrument equipped with Raney-Ni cartridge at a rate of 1 mL/min at 50 psi and 60° C. After 18 h. the acetic acid was removed under reduced pressure and the remaining residue was dissolved in MeOH. The methanolic solution was passed through a 0.2 μm teflon syringe filter. The methanolic filtrate was purified by reverse phase HPLC (Gemini 50×100 5 μm column. Run 1:3 min, 90-10%. Run 2, 5 min 0-10%. Run 3, 10 min, 0-20%. The product fractions were concentrated to dryness on a Genevac HT-4 instrument to afford 3-(aminomethyl)-6-methyl-4-[(methyloxy)methyl]-2(1H)-pyridinone as a pale grey waxy solid (900 mg, 70.2% yield) LCMS MH+=183.0 1H NMR (400 MHz, DMSO-d6) δ 8.40 (br. s., 1H), 6.10 (s, 1H), 4.39 (s, 2H), 3.66 (br. s., 2H), 3.32 (s, 3H), 2.19 (s, 3H).

後処理

  1. customAfter 18 h. the acetic acid was removed under reduced pressure
  2. dissolutionthe remaining residue was dissolved in MeOH
  3. filtrationfilter
  4. customThe methanolic filtrate was purified by reverse phase HPLC (Gemini 50×100 5 μm column
  5. custom3 min, 90-10%
  6. custom2, 5 min 0-10%
  7. custom3, 10 min, 0-20%
  8. concentrationThe product fractions were concentrated to dryness on a Genevac HT-4 instrument

出典と根拠

ORDレコード
ord-b9e71bfefb2e4705a037dfbeefe77126
出典データセット
uspto-grants-2016_09
特許番号
US09446041B2

反応ノート

読み込み中…